Abstract | OBJECTIVE: METHODS: Thirty BALB/c male mices were randomly divided into three groups: placebo control, untreated asthma, and budesonide-treated asthma. The asthma group were induced by intraperitoneal injection of 10% ovalbumin (OVA ) on days 1, 8 and 15, and then from days 22 to 34, challenged by inhalation of 2% OVA aerosol every other day. The budesonide-treated asthma group received an inhalation of budesonide (1 mg ) before OVA challenge. The pathological changes of the airway were assessed by hematoxylin and eosin staining. The immunohistochemistry was used to estimate the expression of SDF-1 in the lung. RT-PCR was used to evaluate the expression of CXCR4 in the lung. RESULTS: Compared with the control group, SDF-1 and CXCR4 expression in the lung in the untreated asthma group increased significantly (p<0.05). The budesonide-treated asthma group demonstrated significantly decreased SDF-1 (0.426+/-0.052 vs 0.361+/-0.065; p<0.05) and CXCR4 (0.829+/-0.027 vs 0.723+/-0.094; p<0.05) expression in the lung as compared with the untreated asthma group. Both SDF-1 (r=0.744, p<0.01) and CXCR4 (r=0.553, p<0.01)were positively correlated with the thickness of the airway wall. CONCLUSIONS:
|
Authors | Bin Luan, Xian-Jie Huang, Jun-Ying Qiao |
Journal | Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
(Zhongguo Dang Dai Er Ke Za Zhi)
Vol. 12
Issue 3
Pg. 215-8
(Mar 2010)
ISSN: 1008-8830 [Print] China |
PMID | 20350434
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- CXCR4 protein, mouse
- Chemokine CXCL12
- Receptors, CXCR4
- Budesonide
|
Topics |
- Airway Remodeling
(drug effects)
- Animals
- Asthma
(drug therapy, metabolism, pathology)
- Budesonide
(pharmacology)
- Chemokine CXCL12
(analysis)
- Male
- Mice
- Mice, Inbred BALB C
- Receptors, CXCR4
(analysis, genetics)
|